At the forefront of therapeutic research, Rare Power is pioneering novel pharmacological treatments specifically targeting Huntington's Disease, Spinocerebellar Ataxias and Amyotrophic Lateral Sclerosis. Our drug development pipeline is progressing steadily towards Investigational New Drug (IND)-enabling studies and clinical trials.